isopentenyladenosine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abate, M; Bifulco, M; Ciaglia, E; D'alessandro, A; Gazzerro, P; Laezza, C; Picardi, P; Pisanti, S; Ranieri, R | 1 |
| Abate, M; Bifulco, M; Catapano, G; Ciaglia, E; Franceschelli, S; Gazzerro, P; Laezza, C; Pisanti, S; Seneca, V; Torelli, G; Vitale, M | 1 |
2 other study(ies) available for isopentenyladenosine and Glioma
| Article | Year |
|---|---|
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Isopentenyladenosine; Killer Cells, Natural; Mice; Xenograft Model Antitumor Assays | 2018 |
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Down-Regulation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Glioma; Humans; Isopentenyladenosine; Mice; Mice, Nude; Neoplasm Proteins; Phosphorylation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptor Protein-Tyrosine Kinases; Signal Transduction; Ubiquitination | 2017 |